ID   GR [Human LCL]
AC   CVCL_C5VZ
DR   PRIDE; PXD004233
DR   Wikidata; Q116049084
RX   PubMed=24616531;
RX   PubMed=26280087;
RX   PubMed=34925382;
CC   HLA typing: A*01:01,03:01; B*07:02,27:05; C*02:02,07:02 (PubMed=34925382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: HLA class I peptidome analysis by proteomics.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=24616531; DOI=10.1073/pnas.1321458111; PMCID=PMC3970485;
RA   Mommen G.P.M., Frese C.K., Meiring H.D., van Gaans-van den Brink J.A.M.,
RA   de Jong A.P.J.M., van Els C.A.C.M., Heck A.J.R.;
RT   "Expanding the detectable HLA peptide repertoire using
RT   electron-transfer/higher-energy collision dissociation (EThcD).";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:4507-4512(2014).
//
RX   PubMed=26280087; DOI=10.1021/jacs.5b06586; PMCID=PMC4603548;
RA   Marino F., Bern M., Mommen G.P.M., Leney A.C.,
RA   van Gaans-van den Brink J.A.M., Bonvin A.M.J.J., Becker C.,
RA   van Els C.A.C.M., Heck A.J.R.;
RT   "Extended O-GlcNAc on HLA class-I-bound peptides.";
RL   J. Am. Chem. Soc. 137:10922-10925(2015).
//
RX   PubMed=34925382; DOI=10.3389/fimmu.2021.796584; PMCID=PMC8671986;
RA   Mukherjee S., Sanchez-Bernabeu A., Demmers L.C., Wu W., Heck A.J.R.;
RT   "The HLA ligandome comprises a limited repertoire of O-GlcNAcylated
RT   antigens preferentially associated with HLA-B*07:02.";
RL   Front. Immunol. 12:796584.1-796584.10(2021).
//